Teva Pharmaceutical Industries Limited
TEVJF
$28.36
-$4.48-13.64%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 1.41B | 712.00M | -158.00M | -1.29B | -1.64B |
| Total Depreciation and Amortization | 1.00B | 1.01B | 1.02B | 1.03B | 1.06B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 604.00M | 1.18B | 1.49B | 2.16B | 2.26B |
| Change in Net Operating Assets | -1.37B | -1.84B | -964.00M | -638.00M | -435.00M |
| Cash from Operations | 1.65B | 1.07B | 1.39B | 1.27B | 1.25B |
| Capital Expenditure | -501.00M | -488.00M | -500.00M | -501.00M | -498.00M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | 0.00 | -15.00M |
| Divestitures | 34.00M | 38.00M | 68.00M | 60.00M | 43.00M |
| Other Investing Activities | 1.20B | 1.22B | 1.34B | 1.29B | 1.26B |
| Cash from Investing | 737.00M | 774.00M | 907.00M | 849.00M | 792.00M |
| Total Debt Issued | 2.31B | 2.31B | 2.31B | -- | -- |
| Total Debt Repaid | -4.12B | -4.80B | -4.35B | -3.01B | -1.64B |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -337.00M | -366.00M | -364.00M | -375.00M | -150.00M |
| Cash from Financing | -2.15B | -2.87B | -2.41B | -3.38B | -1.79B |
| Foreign Exchange rate Adjustments | 21.00M | -90.00M | 19.00M | -25.00M | -174.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | 1.00M | 0.00 |
| Net Change in Cash | 256.00M | -1.12B | -96.00M | -1.29B | 74.00M |